• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why NIO Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

    8/29/23 12:51:54 PM ET
    $AEHL
    $AGIL
    $AHG
    $AIXI
    Building Materials
    Industrials
    Professional Services
    Consumer Discretionary
    Get the next $AEHL alert in real time by email

    Gainers

    • Axcella Health Inc. (NASDAQ:AXLA) shares climbed 196% to $0.3335 after the company announced it was granted a patent for long COVID fatigue treatment.
    • Tivic Health Systems, Inc. (NASDAQ:TIVC) gained 73.4% to $3.37 after falling 11% on Monday. Tivic Health Systems inked a pact to make its products available on AmerisourceBergen’s third-party marketplace.
    • iCoreConnect Inc. (NASDAQ:ICCT) shares gained 70.4% to $2.7089 after dipping 20% on Monday.
    • LifeVantage Corporation (NASDAQ:LFVN) gained 28.6% to $6.62 after the company posted fourth-quarter results and declared a special one-time cash dividend of $0.40 per share of common stock.
    • EBET, Inc. (NASDAQ:EBET) rose 28% to $0.0501.
    • Akso Health Group (NASDAQ:AHG) surged 25.6% to $0.6661.
    • Big Lots, Inc. (NYSE:BIG) gained 23.3% to $7.78 following better-than-expected quarterly results.
    • Globalstar, Inc. (NYSE:GSAT) rose 21% to $1.2850 after the company announced it appointed Dr. Paul Jacobs as CEO and announced an agreement to license XCOM Labs technology.
    • UP Fintech Holding Limited (NASDAQ:TIGR) gained 20.3% to $4.3450 following strong quarterly results.
    • Shineco, Inc. (NASDAQ:SISI) shares rose 20% to $0.1732 after declining over 3% on Monday.
    • Caravelle International Group (NASDAQ:CACO) shares climbed 19.2% to $0.6676 after falling 11% on Monday.
    • PDD Holdings Inc. (NASDAQ:PDD) rose 17.5% to $94.86 after the company reported upbeat second-quarter results.
    • Goosehead Insurance, Inc (NASDAQ:GSHD) gained 17% to $69.64. Goosehead Insurance will replace NuVasive Inc in the S&P SmallCap 600, effective Sept. 1.
    • Taysha Gene Therapies, Inc. (NASDAQ:TSHA) jumped 17% to $2.79. Taysha Gene Therapies received written notice from the Nasdaq informing the company that it had regained compliance.
    • Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) surged 17% to $2.09 after the company and Google Cloud announced a five-year strategic cloud and AI partnership, intended to enable Ginkgo to develop and deploy AI tools for biology and biosecurity.
    • Inhibrx, Inc. (NASDAQ:INBX) climbed 15% to $22.25. Inhibrx announced a $200 million private placement financing.
    • Missfresh Limited (NASDAQ:MF) gained 13.9% to $1.31.
    • Bionomics Limited (NASDAQ:BNOX) climbed 13.6% to $2.00.
    • Lixiang Education Holding Co., Ltd. (NASDAQ:LXEH) jumped 13.2% to $0.59.
    • Secoo Holding Limited (NASDAQ:SECO) gained 12.5% to $0.5607 after gaining 6% on Monday.
    • noco-noco Inc. (NASDAQ:NCNC) shares rose 11.4% to $2.2287 after falling 23% on Monday.
    • Jackson Financial Inc. (NYSE:JXN) gained 9.3% to $37.87. Jackson Financial Inc. will replace NexTier Oilfield Solutions in the S&P SmallCap 600.
    • Chico's FAS, Inc. (NYSE:CHS) rose 9.1% to $5.59 following strong quarterly earnings.
    • The NFT Gaming Company, Inc. (NASDAQ:NFTG) shares gained 8.8% to $0.4788 after adding 6% on Monday.
    • NeuBase Therapeutics, Inc. (NASDAQ:NBSE) rose 7.1% to $0.8565 after falling around 8% on Monday.

    Losers

    • Antelope Enterprise Holdings Limited (NASDAQ:AEHL) shares tumbled 18.8% to $0.3626. Antelope Enterprise Holdings, last week, pre-announced H1 2023 revenue results.
    • Genius Group Limited (NYSE:GNS) fell 16.6% to $1.9187 after jumping 57% on Monday.
    • BioNexus Gene Lab Corp. (NASDAQ:BGLC) declined 16.5% to $1.6786.
    • T2 Biosystems, Inc. (NASDAQ:TTOO) fell 16.4% to $0.28 after declining 9% on Monday.
    • ReTo Eco-Solutions, Inc. (NASDAQ:RETO) dipped 15% to $0.7939.
    • AgileThought, Inc. (NASDAQ:AGIL) fell 14% to $0.1606 after declining 28% on Monday. AgileThought announced a strategic financial restructuring to strengthen financial future.
    • VinFast Auto Ltd. (NASDAQ:VFS) shares fell 13.5% to $71.26 after jumping around 20% on Monday.
    • Xiao-I Corporation (NASDAQ:AIXI) tumbled 13.5% to $2.4050.
    • Pulse Biosciences, Inc. (NASDAQ:PLSE) fell 11.4% to $5.03.
    • JOANN Inc. (NASDAQ:JOAN) declined 10.4% to $1.0399 following weak quarterly earnings.
    • ioneer Ltd (NASDAQ:IONR) fell 9.5% to $6.44.
    • Verra Mobility Corporation (NASDAQ:VRRM) declined 9.4% to $17.65.
    • YS Biopharma Co., Ltd. (NASDAQ:YS) shares fell 8.1% to $1.1208. YS Biopharma recently announced the purchase of shares by company officers.
    • NIO Inc. (NYSE:NIO) fell 7.5% to $10.19 after the company reported worse-than-expected second-quarter financial results and issued third-quarter guidance.
    • First Light Acquisition Group, Inc. (NYSE:FLAG) fell 7.4% to $9.45.
    • Hitek Global Inc. (NASDAQ:HKIT) fell 7.1% to $25.39.
    • HEICO Corporation (NYSE:HEI) fell 4.4% to $160.50 after reporting third-quarter results.

     

    Now Read This: Bitcoin, Ethereum Edge Lower; Pepe, Sui Among Top Losers

    Get the next $AEHL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AEHL
    $AGIL
    $AHG
    $AIXI

    CompanyDatePrice TargetRatingAnalyst
    Goosehead Insurance Inc.
    $GSHD
    2/18/2026$69.00Neutral → Overweight
    Piper Sandler
    Pulse Biosciences Inc
    $PLSE
    1/30/2026$25.00Outperform
    Mizuho
    Verra Mobility Corporation
    $VRRM
    1/26/2026$25.00Neutral
    Analyst
    Heico Corporation
    $HEI
    1/23/2026$385.00Neutral
    Susquehanna
    NIO Inc.
    $NIO
    1/15/2026$6.10Neutral → Outperform
    Macquarie
    Jackson Financial Inc.
    $JXN
    1/6/2026$118.00Underperform → In-line
    Evercore ISI
    Globalstar Inc.
    $GSAT
    12/16/2025$62.00Hold
    Deutsche Bank
    Heico Corporation
    $HEI
    12/12/2025$367.00Buy
    Citigroup
    More analyst ratings

    $AEHL
    $AGIL
    $AHG
    $AIXI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Goosehead Insurance upgraded by Piper Sandler with a new price target

    Piper Sandler upgraded Goosehead Insurance from Neutral to Overweight and set a new price target of $69.00

    2/18/26 7:50:22 AM ET
    $GSHD
    Specialty Insurers
    Finance

    Mizuho initiated coverage on Pulse Biosciences with a new price target

    Mizuho initiated coverage of Pulse Biosciences with a rating of Outperform and set a new price target of $25.00

    1/30/26 6:44:12 AM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    Analyst initiated coverage on Verra Mobility with a new price target

    Analyst initiated coverage of Verra Mobility with a rating of Neutral and set a new price target of $25.00

    1/26/26 10:01:23 AM ET
    $VRRM
    Transportation Services
    Consumer Discretionary

    $AEHL
    $AGIL
    $AHG
    $AIXI
    SEC Filings

    View All

    SEC Form 10-K filed by Verra Mobility Corporation

    10-K - VERRA MOBILITY Corp (0001682745) (Filer)

    2/24/26 4:46:11 PM ET
    $VRRM
    Transportation Services
    Consumer Discretionary

    SEC Form 10-K filed by Jackson Financial Inc.

    10-K - Jackson Financial Inc. (0001822993) (Filer)

    2/24/26 4:14:00 PM ET
    $JXN
    Life Insurance
    Finance

    Verra Mobility Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - VERRA MOBILITY Corp (0001682745) (Filer)

    2/24/26 4:14:23 PM ET
    $VRRM
    Transportation Services
    Consumer Discretionary

    $AEHL
    $AGIL
    $AHG
    $AIXI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Verra Mobility to Present at the Morgan Stanley Technology, Media & Telecom Conference

    MESA, Ariz., Feb. 25, 2026 /PRNewswire/ -- Verra Mobility Corporation (NASDAQ:VRRM), a leading provider of smart mobility technology solutions, announced today that David Roberts, President and Chief Executive Officer, and Craig Conti, Chief Financial Officer, are scheduled to participate in a fireside chat at the Morgan Stanley Technology, Media & Telecom Conference on Tuesday, March 3, 2026, at 12:20pm PST. About Verra MobilityVerra Mobility Corporation (NASDAQ:VRRM) is a leading provider of smart mobility technology solutions that make transportation safer, smarter and more c

    2/25/26 4:05:00 PM ET
    $VRRM
    Transportation Services
    Consumer Discretionary

    Verra Mobility Announces Fourth Quarter and Full Year 2025 Financial Results

    Full year 2025 revenue of $979.1 millionFull year 2025 net income of $136.6 millionFull year 2025 net cash provided from operations of $255.8 millionEntered into new five-year contract with the New York City Department of TransportationRepurchased $133.4 million of shares of common stock during the fourth quarter of 2025Establishing fiscal year 2026 guidanceMESA, Ariz., Feb. 24, 2026 /PRNewswire/ -- Verra Mobility Corporation (NASDAQ:VRRM), a leading provider of smart mobility technology solutions, announced today the financial results for the fourth quarter and full year ended December 31, 2025.

    2/24/26 4:05:00 PM ET
    $VRRM
    Transportation Services
    Consumer Discretionary

    Virewirx Awarded $1.9M Small Business Innovation Research (SBIR) Contract from Office of the Under Secretary of War (OUSW)

    Virewirx system to incorporate Globalstar XCOM RAN Private 5G Platform Virewirx has been awarded a Phase II $1.9 million Small Business Innovation Research (SBIR) OUSW (R&E) FutureG contract from the Office of the Under Secretary of War (OUSW) to develop an advanced 5G system designed to perform reliably in challenging Radio Frequency (RF) environments. This breakthrough technology will enable mission-critical communications in previously impossible environments, ensuring warfighters maintain connectivity for coordination, safety, and operational success in ships, hangars, and other demanding locations where traditional wireless systems fail. Virewirx selected telecom leader Globalstar

    2/24/26 9:16:00 AM ET
    $GSAT
    Telecommunications Equipment
    Consumer Discretionary

    $AEHL
    $AGIL
    $AHG
    $AIXI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Goldberg Louis bought $250,039 worth of shares (5,575 units at $44.85) (SEC Form 4)

    4 - Goosehead Insurance, Inc. (0001726978) (Issuer)

    2/25/26 7:28:44 PM ET
    $GSHD
    Specialty Insurers
    Finance

    New insider Goldberg Louis claimed ownership of 5,575 shares (SEC Form 3)

    3 - Goosehead Insurance, Inc. (0001726978) (Issuer)

    2/25/26 7:25:44 PM ET
    $GSHD
    Specialty Insurers
    Finance

    Chief Commercial Officer Danahy Kevin Patrick exercised 5,000 shares at a strike of $1.53 and sold $118,200 worth of shares (5,000 units at $23.64) (SEC Form 4)

    4 - PULSE BIOSCIENCES, INC. (0001625101) (Issuer)

    2/23/26 8:55:39 PM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    $AEHL
    $AGIL
    $AHG
    $AIXI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Goldberg Louis bought $250,039 worth of shares (5,575 units at $44.85) (SEC Form 4)

    4 - Goosehead Insurance, Inc. (0001726978) (Issuer)

    2/25/26 7:28:44 PM ET
    $GSHD
    Specialty Insurers
    Finance

    Director Lewis Darwin bought $20,651 worth of shares (3,955 units at $5.22), increasing direct ownership by 3% to 135,508 units (SEC Form 4)

    4 - Lifevantage Corp (0000849146) (Issuer)

    2/11/26 4:32:08 PM ET
    $LFVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Lewis Darwin bought $5,265 worth of shares (805 units at $6.54), increasing direct ownership by 0.62% to 131,553 units (SEC Form 4)

    4 - Lifevantage Corp (0000849146) (Issuer)

    12/17/25 4:23:51 PM ET
    $LFVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEHL
    $AGIL
    $AHG
    $AIXI
    Leadership Updates

    Live Leadership Updates

    View All

    BioNexus Gene Lab Corp. Completes Chemrex Governance Restructuring; Appoints Matthew Barsing as Chairman

    Enhanced board oversight aligns subsidiary with disciplined capital allocation and strategic evaluation framework KUALA LUMPUR, Malaysia, Feb. 23, 2026 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ:BGLC) ("BioNexus" or the "Company"), today announced the completion of a governance restructuring of its wholly owned subsidiary, Chemrex Corporation Sdn. Bhd. ("Chemrex"). As part of this restructuring, Chemrex's board has been streamlined to two directors: Matthew L. Barsing, ChairmanAngeline Chong, Chief Financial Officer of BioNexus, Director New officers are expected to be appointed in the coming months. Chemrex remains a wholly owned private subsidiary of BioNexus and operates un

    2/23/26 8:30:00 AM ET
    $BGLC
    Medical Specialities
    Health Care

    Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors

    Pulse Biosciences, Inc. (NASDAQ:PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced the appointment of Maria Sainz to its Board of Directors effective as of January 9, 2026. "We are delighted to welcome Maria to our Board of Directors," said Pulse Biosciences' Co-Chairman of the Board Robert W. Duggan. "She brings an exceptionally strong track record of guiding both public and private medical device companies through growth, commercialization, viability, and scale. Her strategic and operational expertise will be invaluable as Pulse begins creating and disrupting interventional m

    1/9/26 7:00:00 AM ET
    $AVNS
    $HYPR
    $OFIX
    Industrial Specialties
    Health Care
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Medical/Dental Instruments

    LifeVantage Appoints Seasoned Technology Executive Mike Edwards as Chief Technology Officer to Drive Digital Innovation

    SALT LAKE CITY, Jan. 07, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced the addition of Mike Edwards as Chief Technology Officer. Edwards brings more than 25 years of experience as an accomplished senior executive specializing in technology leadership and enterprise transformation. "Mike is a strategic leader with a strong track record of translating technological innovation into measurable business impact and we are delighted to have him join the LifeVantage team," said Steve Fife, President and CEO of LifeVantage. "His expertise in eCo

    1/7/26 4:05:00 PM ET
    $LFVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEHL
    $AGIL
    $AHG
    $AIXI
    Financials

    Live finance-specific insights

    View All

    Verra Mobility Announces Fourth Quarter and Full Year 2025 Financial Results

    Full year 2025 revenue of $979.1 millionFull year 2025 net income of $136.6 millionFull year 2025 net cash provided from operations of $255.8 millionEntered into new five-year contract with the New York City Department of TransportationRepurchased $133.4 million of shares of common stock during the fourth quarter of 2025Establishing fiscal year 2026 guidanceMESA, Ariz., Feb. 24, 2026 /PRNewswire/ -- Verra Mobility Corporation (NASDAQ:VRRM), a leading provider of smart mobility technology solutions, announced today the financial results for the fourth quarter and full year ended December 31, 2025.

    2/24/26 4:05:00 PM ET
    $VRRM
    Transportation Services
    Consumer Discretionary

    Globalstar, Inc. Earnings Release and Call Notice

    Globalstar, Inc. (NASDAQ:GSAT) will announce its fourth quarter and full year 2025 financial and operating results on Friday, February 27, 2026 before the market opens. The release will be available over the wire and from the Globalstar, Inc. website at www.globalstar.com. The Company will also conduct a conference call on Friday, February 27, 2026 at 9:00 a.m. Eastern Time (ET) to discuss these results. Details are as follows: Earnings Call: The earnings call will be available via webcast from the following link.   Webcast Link: https://edge.media-server.com/mmc/p/8v6dbgc2   To participate in the earnings call via teleconference, participants should register at t

    2/19/26 4:15:00 PM ET
    $GSAT
    Telecommunications Equipment
    Consumer Discretionary

    Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2025 Financial Results

    Pulse Biosciences, Inc. (NASDAQ:PLSE), developer of the novel nPulse™ technology using proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced business updates and financial results for the fourth quarter and full year ended December 31, 2025. Recent Business Highlights Endocardial Catheter AF Ablation Highlighted 100% procedural success, or freedom from atrial fibrillation (AF), at 6 months and 96% procedural success at one year, of evaluable patients, following treatments with the nPulse Cardiac Catheter System in the first-in-human feasibility study which was presented as late-breaking data at the 31st Annual AF Symposium Meeting. Receiv

    2/19/26 4:05:00 PM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    $AEHL
    $AGIL
    $AHG
    $AIXI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by iCoreConnect Inc.

    SC 13G/A - iCoreConnect Inc. (0001906133) (Subject)

    12/12/24 9:44:00 PM ET
    $ICCT
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by iCoreConnect Inc.

    SC 13G/A - iCoreConnect Inc. (0001906133) (Subject)

    12/5/24 4:08:58 PM ET
    $ICCT
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by ReTo Eco-Solutions Inc.

    SC 13G/A - ReTo Eco-Solutions, Inc. (0001687277) (Subject)

    12/3/24 8:32:02 AM ET
    $RETO
    Industrial Machinery/Components
    Industrials